Impact of Multidisciplinary Teams on Lung Cancer Treatment and Survival
Author Information
Author(s): Forrest L M, McMillan D C, McArdle C S, Dunlop D J
Primary Institution: University Department of Surgery, Royal Infirmary, Glasgow
Hypothesis
The introduction of a multidisciplinary team improves treatment and survival outcomes for patients with inoperable non-small-cell lung cancer.
Conclusion
The introduction of a multidisciplinary team was associated with increased chemotherapy use and improved median survival for patients with inoperable non-small-cell lung cancer.
Supporting Evidence
- In 2001, 23% of patients received chemotherapy compared to 7% in 1997.
- Median survival increased from 3.2 months in 1997 to 6.6 months in 2001.
- 44% of patients received palliative care only in 2001 compared to 58% in 1997.
Takeaway
This study found that having a team of different doctors working together helped lung cancer patients live longer and get better treatment.
Methodology
The study compared treatment and survival outcomes of patients diagnosed with inoperable NSCLC before and after the introduction of a multidisciplinary team.
Potential Biases
Potential for 'stage drift' affecting survival outcomes.
Limitations
The study was conducted at a single center, which may limit the generalizability of the findings.
Participant Demographics
Majority of patients were over 60 years old, male, and from deprived areas.
Statistical Information
P-Value
P<0.001
Confidence Interval
2.4–4.1 months for 1997; 3.7–9.5 months for 2001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website